Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
3.110
-0.110 (-3.42%)
At close: Nov 13, 2026, 4:00 PM EST
2.950
-0.160 (-5.14%)
Pre-market: Nov 16, 2026, 7:29 AM EST

Entera Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5428978172181
Market Cap Growth
307.50%13.93%351.66%-17.80%-74.05%308.59%
Enterprise Value
276817110754
Last Close Price
3.111.942.120.600.732.81

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-2118.17431.41-156.95141.91
PB Ratio
1.976.799.661.671.793.59
P/TBV Ratio
1.976.799.661.671.793.59

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-1919.05394.91-51.0594.51

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.040.030.040.010.01
Net Debt / Equity Ratio
-0.97-0.50-1.04-1.02-1.04-1.09
Net Debt / EBITDA Ratio
14.450.580.881.200.912.02
Net Debt / FCF Ratio
16.760.891.231.450.972.71
Asset Turnover
-0.000.02-0.010.03
Quick Ratio
123.533.337.4710.109.367.93
Current Ratio
128.416.947.6310.329.588.01
Return on Equity (ROE)
-20.33%-108.01%-103.34%-80.30%-76.17%-81.04%
Return on Assets (ROA)
-7.81%-56.77%-56.64%-44.65%-43.06%-42.77%
Return on Capital Employed (ROCE)
-6.70%-83.60%-116.70%-83.30%-114.30%-53.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-13.01%-12.86%-12.22%-51.42%-62.15%-15.04%
FCF Yield
-2.92%-8.40%-8.73%-42.38%-59.65%-11.21%
Buyback Yield / Dilution
-64.72%-22.68%-29.79%-0.69%-10.23%-41.90%
SEC Filings: 10-K · 10-Q